In a Bloomberg BusinessWeek article republished in Yahoo Finance, life sciences partner Michael Beauvais commented on the optimistic outlook for life sciences dealmaking surrounding the JP Morgan Healthcare Conference.
Among the sectors within life sciences and broader healthcare industry that are attracting M&A interest include targeted cancer treatments, weight-loss and diabetes drugs, neuroscience therapies, and gene-editing technologies such as CRISPR.
The Nasdaq Biotechnology Index is the highest it’s been since early 2022 and looks for a return to prepandemic deal levels.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.